Navigation Links
Study identifies another strategy for normalizing tumor blood supply
Date:2/20/2008

Manipulating levels of nitric oxide (NO), a gas involved in many biological processes, may improve the disorganized network of blood vessels supplying tumors, potentially improving the effectiveness of radiation and chemotherapy. In an upcoming issue of the journal Nature Medicine, researchers from the Steele Laboratory of Radiation Oncology at Massachusetts General Hospital (MGH) report an experiment in which NO production was selectively suppressed in tumor cells while being maintained in blood vessels. The result was a significant improvement in the appearance and function of the tumors blood supply.

Our finding suggest that the creation of perivascular NO gradients differences between the levels produced in blood vessels and those found in tumor tissue may be able to normalize tumor vasculature, says Dai Fukumura, MD, PhD, of the Steele Laboratory, who led the study. Combining the use of angiogenesis inhibitors, which normalize vasculature through a different mechanism, with the blockade of nonvascular NO production may produce even greater improvement in therapeutic outcomes.

The blood vessels that develop around and within tumors are leaky and disorganized, interfering with delivery of chemotherapy drugs and with radiation treatment, which requires an adequate oxygen supply. Combining angiogenesis inhibitors, drugs that suppress the growth of blood vessels, with traditional anticancer therapies has improved patient survival in some tumors. That success supports a theory developed by Rakesh K. Jain, PhD, director of the Steele Laboratory, that the agents temporarily normalize blood vessels, creating a period during which other treatments can be more effective.

Since angiogenesis is one of many physiologic activities mediated by NO, the MGH research team hypothesized that restricting NO production to blood vessels also could improve tumor vasculature. Using cancer cells from human brain tumors, they suppressed the enzyme
'/>"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Grant to study if early BPA exposure leads to late prostate cancer
2. Mailman School PH study finds increase in thyroid diseases risk from exposure at Chernobyl
3. Study: low-income women more likely to suffer from postpartum depression
4. Study Shows New Therapy Opens Blocked Fallopian Tubes, Returns Fertility Without Surgery
5. Study suggests antibiotic may prevent dreaded brain fever
6. Study: Before a CT scan or angiogram, many people should take inexpensive drug to protect kidneys
7. Study Suggests Glucosamine Wont Ease Hip Arthritis
8. Scientists using laser light to detect potential diseases via breath samples, says new study
9. Major study links insurance status to advanced stage in multiple cancers
10. 7-year neck pain study sheds light on best care
11. PLC Systems Files IDE Supplement to Begin Pivotal Study of RenalGuard(TM) and Provides Update on Planned Development Timeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...all on John McCain to commit to develop a National...PAUL, Minn., Sep. 5 /PRNewswire-USNewswire/ -- The...ht with no mention of the,domestic AIDS epidemic i...the epidemic overseas. Neither Presidential nomine...ov. Sarah Palin mentioned AIDS in their remarks,to...
(Date:9/5/2008)...l Institute of Diabetes and Digestive and Kidney D...f Health (NIH), announces awards to eight academic... of urologic chronic pelvic pain disorders by look...e total research investment for the five-year proj...he launch of this novel research effort is an exce...
(Date:9/5/2008)... Sept. 5 /PRNewswire-USNewswire/ -- U.S. citizens ... to Cuban victims of Hurricane,Gustav, which is th...p://www.PanAmericanRelief.org ), "Donations will ... need,after this natural disaster," says Marc Wach...ive at the Pan American Development Foundation, (h...
(Date:9/5/2008)...k is greatest for those overweight or obese at age... -- Almost half of all American adults will develo...odds increase if they are obese in middle age, a n... painful condition increased as his or her body-ma...f North Carolina at Chapel Hill study. People who ...
Breaking Medicine News(10 mins):Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 2Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 3Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2Health News:Almost Half of Adults Will Develop Knee Osteoarthritis by 85 2
...rse for women in childbearing age than previously ...l of Maxillofacial Surgery says//. The study foun... tooth may be an indicator of premature birth. The...20 women in the childbearing age group from Decemb...
...set up in Pakistani Kashmir to provide surgery and...arthquake. The hospital was erected in just 2 hour...ctors and other paramedical staff. The mobile unit...rabad, the Kashmir capital, in four helicopters. T...
...next issue of the British Dental Journal says that...dontic files is not satisfactory when the existing...al practice are used//. Files are instruments that...oots during a root canal procedure. The study exam...
...t by using EEG can predict whether a person may ...esearch reported by Leslie S. Prichep of the New ...richep conducted EEG test on 44 patients and follo...G test proved more than 90 percent accurate in pre...
Other Medicine News:
(Date:9/3/2008)...BRUSSELS, Belgium and GENEVA, Sept. 3 /PRNewswire/...w milestone in CHO based monoclonal antibody,produ... of over 31 grams,per liter. This record level was...chnologies: (1) a high-performance stable Selexis ...stry leading scientists at,Selexis SA using their ...
(Date:9/3/2008)...is analysis showed that Multaq(R) (dronedarone) de...atrial fibrillation or atrial flutter already ...apy, BRIDGEWATER, N.J., Sept. 3 /PRNewswire-First... data from the ATHENA study were presented today a...n Society of Cardiology,congress 2008, in Munich, ...
(Date:9/3/2008)...Company Focuses Operations, Updates Zingo Launch P...tion Strategy Conference Call Tod...ept. 3 /- Anesiva,Inc. (Na...l restructure,operations to focus on commercial an... transition to a specialty pharmaceutical pain man...
(Date:9/3/2008)... SB-509 to be Evaluated in Repeat-Dosing Study in ...ewswire-FirstCall/ -- Sangamo,BioSciences, Inc. (N...a Phase,2 clinical trial (SB-509-801) to evaluate ...ive, degenerative motor-neuron disease for which t...Sangamo,s drug, SB-509, is an injectable formulati...
Breaking Medicine Technology:Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5Nationwide Progress Poll Reveals Increased Efforts by Hospitals to Control MRSA Infection 2450 1Nationwide Progress Poll Reveals Increased Efforts by Hospitals to Control MRSA Infection 2450 2Nationwide Progress Poll Reveals Increased Efforts by Hospitals to Control MRSA Infection 2450 3Nventa to Present at Bio 2008 International Convention 2448 1Same day pregnancy test provides valuable guidance to pre surgery patients 22008 1Same day pregnancy test provides valuable guidance to pre surgery patients 22008 2New molecular imaging techniques may lead to advances in disease treatment 6021 1New molecular imaging techniques may lead to advances in disease treatment 6021 2
...e offers five questions to help women,learn about ... 12, 2007 – According to a new,GfK Roper Pub...onal,nonprofit cancer support organization, while ...hey know at least a fair amount,about breast cance...gress made in treatment. Fewer than one out of fou...
...Md., June 13, 2007 /PRNewswire-FirstCall/ -- Avalo...is will provide an,update on the Phase I clinical ...sday, June 19, 2007, after the close of the U.S.,f...ference call on,Wednesday, June 20, 2007 at 8 a.m....bers of the media and the general public,can liste...
Other Medicine Technology:Women Well-Informed About Breast Cancer, Yet Lacking Knowledge,About Current Treatments, New Survey Finds 2Women Well-Informed About Breast Cancer, Yet Lacking Knowledge,About Current Treatments, New Survey Finds 3Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial 2Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial 3
LCD monitors.
Camera and light source in one compact "Plug-and-Play" device.
... highly sensitive DR system. It features a 17 x 17...eral radiographic applications. Versatile and flex...nfigurations. , ,With advanced Canon technolo...ient images with reduced dose. The CXDI-40Cs Amorp...
...ow Unit is a flexible, total solution. , ,Kojair T...theaters since 1983. A major part of our productio...perience from all the different areas of clean-air... is a comprehensive supplier. We are able to keep ...
Medicine Products: